Palvella Therapeutics PVLA
NASDAQ PVLA
$134.21 -3.72 (-2.70%)
As of: Oct 1, 2026 · 2:55 PM EDT

Palvella Therapeutics (PVLA) Accounts Payables (2013 - 2026)

Updated

Palvella Therapeutics' Accounts Payables came in at $6.79 million for Q2 2026, up 48.9% from $4.56 million a year earlier and up 24.7% from the prior quarter.

Analysis

Palvella Therapeutics (PVLA) Accounts Payables (2013 - 2026) Analysis & Trends

At the end of FY2025, Palvella Therapeutics' Accounts Payables was $4.6 million, up 0.2% from FY2024.

  • Accounts Payables carries a five-year compound annual growth rate of -9.9% (FY2020 to FY2025).
  • Going back by year, Accounts Payables was $4.59 million in FY2024 (+390.0%), $936,000 in FY2023 (-77.5%), $4.15 million in FY2022 (-51.7%) and $8.61 million in FY2021 (+11.4%).
  • The Q2 2026 figure represents the highest quarterly Accounts Payables since Q2 2023.
  • Year-over-year, Accounts Payables has increased for seven consecutive quarters, with growth averaging 160.9% over the last eight quarters.
  • The fastest year-over-year change in Accounts Payables over five years came in Q4 2024 (growth of 390.0%), and the weakest in Q2 2024 (a decline of 87.3%).
  • Business Quant data shows PVLA's Accounts Payables at $5.44 million (Q1 2026), $4.6 million (Q4 2025) and $3.48 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 9.22 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 33.30 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 3.83 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 4.26 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -22.89 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 2.87 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 674.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.58 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 429.50 Mn
10 Palvella Therapeutics 1.99 Bn 1.73 Bn - 6.79 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.79 Mn
Mar 31, 2026 5.44 Mn
Dec 31, 2025 4.60 Mn
Sep 30, 2025 3.48 Mn
Jun 30, 2025 4.56 Mn
Mar 31, 2025 4.44 Mn
Dec 31, 2024 4.59 Mn
Sep 30, 2024 801,000.00
Jun 30, 2024 969,000.00
Mar 31, 2024 1.52 Mn
Dec 31, 2023 936,000.00
Sep 30, 2023 2.82 Mn
Jun 30, 2023 7.60 Mn
Mar 31, 2023 5.83 Mn
Dec 31, 2022 4.15 Mn
Sep 30, 2022 3.64 Mn
Jun 30, 2022 10.79 Mn
Mar 31, 2022 14.08 Mn
Dec 31, 2021 8.61 Mn
Sep 30, 2021 19.69 Mn
API Access

Palvella Therapeutics Accounts Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accounts-payables&ticker=PVLA&period=max&api_key=YOUR_API_KEY